Check out our various syndromic testing webinars that demonstrate the diverse capabilities of the QIAstat-Dx.
The development of rapid multiplex PCR tests enables the detection of almost all respiratory viruses in a few hours. These tests provide a deeper understanding of respiratory viruses’ epidemiology among children or adults, as well as community- or hospital-acquired infections. They also allow clinicians to consider viral etiology to improve isolation management, antibiotic use, or a patient’s length of stay.
While these tests offer clear benefits for some patient populations, labs looking to adopt rapid multiplex PCR testing must balance their costs against the impact on patient care.
In this webinar, Dr. Benoit Visseaux of Bichat Claude Bernard Hospital, a university hospital in Paris, shares his experience implementing multiplex PCR testing for respiratory viruses. He discusses the challenges of balancing costs with improved patient outcomes.
Modern PCR technologies are changing the workflow of medical microbiology laboratories, making it possible to get molecular test results within an hour instead of days to weeks. Smaller and cheaper analyzers also make multiplex PCR techniques possible for smaller laboratories without a molecular testing department.
Although the Ikazia hospital is one of the smaller hospitals in Rotterdam (360 beds), it has offered a “24/7” PCR service to its medical staff for 10 years, starting with molecular screening for methicillin-resistant Staphylococcus aureus in 2009. The hospital has expanded its portfolio in the last decade, and most recently, rolled out multiplex syndromic testing in 2018.
In this webinar, Dr. Michiel van Rijn speaks about the implementation of a rapid 24/7 PCR service in his hospital and the effects of this service on patient outcomes and clinical decision making strategies. In particular, he shares his experiences with DiagCORE syndromic testing and his expectation of further use of this technology in the future.
Acute respiratory tract infections are caused by a wide range of viral and bacterial pathogens and may share similar clinical presentations that make it difficult for physicians to diagnose based on symptoms alone. Syndromic testing with multiplex molecular panels offers clinical labs a way to quickly distinguish between a broad array of respiratory pathogens.
In this webinar, Dr. Steve Young of Tricore Reference Laboratories presents a new technology for multiplexed respiratory testing in acutely ill patients. He shares data demonstrating the capabilities of syndromic respiratory testing as well as his impressions on the ease of doing comprehensive syndromic testing using the QIAstat-Dx Analyzer.
Acute respiratory tract infections are caused by a wide range of viral and bacterial pathogens, which are difficult to identify with clinical presentation alone. Syndromic testing solutions, with multiplex molecular panels, offer clinical labs a way to quickly identify the cause of infection and improve patient care. How do these new technologies compare to the current methods?
Dr. Vincent Thibault is Head of the Rennes University Hospital Virology Lab, a 1,600-bed university hospital that tests over 3,000 respiratory samples per year. In this webinar he compares the laboratory workflow of the DiagCORE Respiratory Panel V2 to classical molecular methods (or approaches). He also discusses the impact of Ct values on evaluating test performance and identifying co-infection.